Home » FDA accepts Rhythm Pharmaceuticals' setmelanotide application for review financeFDA accepts Rhythm Pharmaceuticals' setmelanotide application for reviewAugust 20, 2025financeposted on Aug. 20, 2025 at 9:08 pm [ad_1] FDA accepts Rhythm Pharmaceuticals' setmelanotide application for review [ad_2] READ SOURCE Share on FacebookShare on TwitterShare on LinkedInShare on RedditnewscabalAugust 20, 2025 You Might Also LikefinanceTechnologyIDMERIT’s Rise and Rise in Global KYC Solutions IndustryMarch 14, 2026financeSpirit Airlines files for bankruptcy protection for second time in a yearAugust 29, 2025financeQuality Street Christmas chocolate tubs shrink AGAIN with six less sweetsAugust 29, 2025financeGovernment pilot aims to make electric vehicles more accessibleAugust 29, 2025US stock futures edge lower after S&P 500 hits record high; PCE data in focusAugust 29, 2025financeElectric cars eligible for £3,750 discount announcedAugust 28, 2025financeBritish Gas customers urged to wash, clean and cook from 2pm to 4pmAugust 28, 2025financeReform UK retreats on plan to deport women and childrenAugust 27, 2025financeHow hard will Trump’s 50% tariff hit India, and what is Delhi doing about it?August 27, 2025
